Postoperative adjuvant chemotherapy with mitomycin C and UFT for curatively resected rectal cancer. Results from the Cooperative Project No.7 Group of the Japanese Foundation for Multidisciplinary Treatment of Cancer

• DOI: 10.1007/bf00539213
• Publication Date: 2004-11-18T12:43:38Z
• Authors: S. Kodaira; K. Kikuchi; Y. Kunii; M. Yasutomi; T. Takahashi; K. Hojo; T. Kato; T. Tominaga
• Keywords: 03 medical and health sciences; 0302 clinical medicine; 3. Good health

Background. This study was conducted to evaluate the significance of postoperative adjuvant chemotherapy using mitomycin C (MMC) and UFT (tegafur; uracil at 1:4 molar ratio) in combination for rectal cancer.